In the latest trading session,, 29.52 million Synaptogenix Inc (NASDAQ:SNPX) shares changed hands as the company’s beta touched 1.30. With the company’s most recent per share price at $4.11 changing hands around $1.7 or 70.75% at last look, the market valuation stands at $5.72M. SNPX’s current price is a discount, trading about -22.87% off its 52-week high of $5.05. The share price had its 52-week low at $1.84, which suggests the last value was 55.23% up since then.
Analysts gave the Synaptogenix Inc (SNPX) stock a consensus recommendation rating of Hold, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 1 recommended SNPX as a Hold, 0 felt it is a Buy and 0 rated the stock as Underweight. Synaptogenix Inc’s EPS for the current quarter is expected to be 0.
Synaptogenix Inc (NASDAQ:SNPX) trade information
Instantly SNPX is in green as seen in intraday trades today. With action 53.83%, the performance over the past five days has been green. The company’s shares are showing year-to-date upside of 18.59%, with the 5-day performance at 53.83% in the green. However, in the 30-day time frame, Synaptogenix Inc (NASDAQ:SNPX) is 71.46% up.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 29.61%.
SNPX Dividends
Synaptogenix Inc is expected to release its next quarterly earnings report in July.
STATE STREET CORP holds the second largest percentage of outstanding shares.
Among Mutual Funds, the top two as of Mar 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 7.31 shares estimated at $28155.0 under it, the former controlled 0.53% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.20% of the shares, roughly 2.74 shares worth around $10549.0.
